Search research articles
Contact Us
Filters
Showing results (171-180 of 230) with videos related to
Page
of 23
Sort By:
Molecular and Biochemical Parasitology
|
April 24, 1999
Phylogenetic position of the kinetoplastids, Cryptobia bullocki, Cryptobia catostomi, and Cryptobia salmositica and monophyly of the genus Trypanosoma inferred from small subunit ribosomal RNA sequences
A D Wright, S Li, S Feng, et al.
Cancer Research
|
August 1, 1980
Protection by testosterone from fluorouracil-induced toxicity without loss of anticancer acitvity against autochthonous murine breast tumors
R L Stolfi, R C Sawyer, R Nayak, et al.
Cancer Treatment Reports
|
March 1, 1984
Phase I evaluation of a biochemically designed combination: PALA, thymidine, and 5-FU
E S Casper, R A Michaelson, N Kemeny, et al.
Cancer Research
|
October 1, 1989
Effects of extracellular matrix on the growth and casein gene expression of primary mouse mammary tumor cells in vitro
J L Chou, Z X Shen, R L Stolfi, et al.
Cancer Treatment Reports
|
January 1, 1980
Clinical pharmacologic effects of thymidine plus 5-FU
T Ohnuma, J Roboz, S Waxman, et al.
The Journal of Parasitology
|
December 1, 1995
The demise of a phylum of protists: phylogeny of Myxozoa and other parasitic cnidaria
M E Siddall, D S Martin, D Bridge, et al.
Cancer Research
|
May 1, 1985
Coordinate inhibition of plasminogen activator and tumor growth by hydrocortisone in mouse mammary carcinoma
R Mira-y-Lopez, E Reich, R L Stolfi, et al.
Methods in Enzymology
|
January 1, 1979
Investigation of crystalline enzyme-substrate complexes of pyridoxal phosphate-dependent enzymes
C M Metzler, P H Rogers, A Arnone, et al.
Cancer Research
|
May 1, 1983
Phase I and clinical pharmacological evaluation of biochemical modulation of 5-fluorouracil with N-(phosphonacetyl)-L-aspartic acid
E S Casper, K Vale, L J Williams, et al.
Cancer Investigation
|
January 1, 1994
Biochemical modulation of tumor cell energy in vivo: II. A lower dose of adriamycin is required and a greater antitumor activity is induced when cellular energy is depressed
D S Martin, R L Stolfi, J R Colofiore, et al.
Page
of 23
Search research articles
Search
Showing results (171-180 of 230) with videos related to
Sort By:
Page
of 23
Molecular and Biochemical Parasitology
|
April 24, 1999
Phylogenetic position of the kinetoplastids, Cryptobia bullocki, Cryptobia catostomi, and Cryptobia salmositica and monophyly of the genus Trypanosoma inferred from small subunit ribosomal RNA sequences
A D Wright, S Li, S Feng, et al.
Cancer Research
|
August 1, 1980
Protection by testosterone from fluorouracil-induced toxicity without loss of anticancer acitvity against autochthonous murine breast tumors
R L Stolfi, R C Sawyer, R Nayak, et al.
Cancer Treatment Reports
|
March 1, 1984
Phase I evaluation of a biochemically designed combination: PALA, thymidine, and 5-FU
E S Casper, R A Michaelson, N Kemeny, et al.
Cancer Research
|
October 1, 1989
Effects of extracellular matrix on the growth and casein gene expression of primary mouse mammary tumor cells in vitro
J L Chou, Z X Shen, R L Stolfi, et al.
Cancer Treatment Reports
|
January 1, 1980
Clinical pharmacologic effects of thymidine plus 5-FU
T Ohnuma, J Roboz, S Waxman, et al.
The Journal of Parasitology
|
December 1, 1995
The demise of a phylum of protists: phylogeny of Myxozoa and other parasitic cnidaria
M E Siddall, D S Martin, D Bridge, et al.
Cancer Research
|
May 1, 1985
Coordinate inhibition of plasminogen activator and tumor growth by hydrocortisone in mouse mammary carcinoma
R Mira-y-Lopez, E Reich, R L Stolfi, et al.
Methods in Enzymology
|
January 1, 1979
Investigation of crystalline enzyme-substrate complexes of pyridoxal phosphate-dependent enzymes
C M Metzler, P H Rogers, A Arnone, et al.
Cancer Research
|
May 1, 1983
Phase I and clinical pharmacological evaluation of biochemical modulation of 5-fluorouracil with N-(phosphonacetyl)-L-aspartic acid
E S Casper, K Vale, L J Williams, et al.
Cancer Investigation
|
January 1, 1994
Biochemical modulation of tumor cell energy in vivo: II. A lower dose of adriamycin is required and a greater antitumor activity is induced when cellular energy is depressed
D S Martin, R L Stolfi, J R Colofiore, et al.
Page
of 23